Assessing new technology: what is best for the patient, the surgeon, and the healthcare system

Assessing new technology: what is best for the patient, the surgeon, and the healthcare system
In this issue of Fertility and Sterility, Sandberg et al (1). present a very thorough meta-analysis on the short- and long-term quality of life outcomes and reintervention rates of surgical and non-surgical technologies and techniques for the uterine sparing treatment of fibroid-related symptoms. They have included available data on surgical abdominal and hysteroscopic myomectomy as well as each Food and Drug Administration approved devices including uterine artery embolization, magnetic resonance imaging-guided HIFU, and laparoscopic and hysteroscopic radiofrequency ablation that utilize ultrasound guidance (2-5).
Source: fertstert.org